Effects of labor analgesia with different concentrations of ropivacaine on maternal body temperature and inflammatory factors

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037844

Enrollment

Unknown

Registered

2020-09-03

Start date

2020-09-07

Completion date

Unknown

Last updated

2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

epidural related maternal fever

Interventions

Two groups:different concentrations of local anesthetics

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old; 2. Primiparas with single head position; 3. Patients with ASA grades 1-2; 4. Patients who voluntarily request labor analgesia.

Exclusion criteria

Exclusion criteria: 1. Patients with premature rupture of membranes for more than 6 hours during analgesia; 2. Patients with body temperature > 37.5 degrees; 3. Patients with less than 4 hours of analgesia; 4. Patients with GBS (+), gestational hypertension and gestational diabetes mellitus complicated with other systemic infections; 5. Those patients whose epidural analgesia is contraindicated.

Design outcomes

Primary

Measure	Time frame
body temprature;inflammatory factors;	—

Secondary

Measure	Time frame
pain VAS score;	—

Countries

China

Contacts

Public ContactXiubin Chen

Shanghai First Maternity and Infant Hospital

chenxiubin@51mch.com+86 18017211609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026